UBS ASSET MANAGEMENT AMERICAS INC 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 09:51 am Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | UBS ASSET MANAGEMENT AMERICAS INC | 1,935,957 1.210% | -9,245,494 (-82.69%) | Filing |
| 2020-02-12 10:12 am Purchase | 2019-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | UBS ASSET MANAGEMENT AMERICAS INC | 11,181,451 7.130% | 922,986 (+9.00%) | Filing |